Potential salvage therapy for accidental intrathecal vincristine administration: A preliminary experimental study

Chemotherapy

Volumn 46, Issue 5, 2000, Pages 322-326

  Özgen, Ünsal ^a   Soylu, Hanifi ^a   Cagatay Onal S ^a   Mizrak, Bülent ^a   Türköz, Yusuf ^a   Onur Kutlu, N ^a   Koçak, Ayhan ^a   Özcan, Cemal ^a   Koltuksuz, Uǧur ^a   Fuat Erten, S ^a   Akçin, Übeyt ^a  

^a INONU UNIVERSITY   (Turkey)

Author keywords

Brain; HOCl; Intrathecal vincristine; Neurotoxicity; Rabbits

Indexed keywords

HYPOCHLOROUS ACID; VINCRISTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RABBIT; TREATMENT OUTCOME;

EID: 0033798322     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007305     Document Type: Article

References (10)

1. Michelagnoli MP, Bailey CC, Wilson I, Livingston J, Kinsey SE: Potential salvage therapy for inadvertent intrathecal administration of vincristine. Br J Haematol 1997;99: 364-367.
2. Williams ME, Walker AN, Bracikowski JP, Garner L, Wilson KD, Carpenter JT: Ascending myeloencephalopathy due to intrathecal vincristine sulfate. A fatal chemotherapeutic error. Cancer 1983:51: 2041-2047.
3. Manelis J, Freundlich E, Ezekiel E, Doron J: Accidental intrathecal vincristine administration. Report of a case. J Neurol 1982;228:209-213.
4. Gaidys WG, Dickerman JD, Walters CL, Young PC: Intrathecal vincristine: Report of a fatal case despite CNS washout. Cancer 1983; 52: 799-801.
5. Meggs WJ, Hoffman RS: Fatality resulting from intraventricular vincristine administration. J Toxicol Clin Toxicol 1998;36: 243-246.
6. Zaragoza MR, Ritchey ML, Walter A: Neurologic consequences of accidental intrathecal vincristine: A case report. Med Pediatr Oncol 1995;24: 61-62.
7. Jackson DV, Wells HB, Atkins JN, Zekan PJ, White DR, Richars F, Cruz JM, Musa HB: Amelioration of vincristine neurotoxicity by glutamic acid. Am J Med 1988;84: 1016-1022.
8. Dyke RW: Treatment of inadvertent intrathecal injection of vincristine. N Engl J Med 1989;321: 1270-1271.
9. Özgen Ü, Savasan S, Stout M, Buck S, Ravindranath Y: Further elucidation of mechanism of resistance to vincristine in myeloid cells: Role of hypochlorous acid in degradation of vincristine by myeloperoxidase. Leukemia 2000;14: 47-51.
10. Slyter H, Liwnicz B, Herrick MK, Mason R: Fatal myeloencephalopathy caused y intrathecal vincristine. Neurology 1980;30: 867-871.